Cargando…
Anticoagulation in COVID-19
Autores principales: | Bradbury, Charlotte A, McQuilten, Zoe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673870/ https://www.ncbi.nlm.nih.gov/pubmed/34921757 http://dx.doi.org/10.1016/S0140-6736(21)02503-4 |
Ejemplares similares
-
How should we use convalescent plasma therapies for the management of COVID-19?
por: Wood, Erica M., et al.
Publicado: (2021) -
Anticoagulation in COVID-19: reaction to the ACTION trial
por: Berger, Jeffrey S, et al.
Publicado: (2021) -
Will helminth co-infection modulate COVID-19 severity in endemic regions?
por: Bradbury, Richard S., et al.
Publicado: (2020) -
Platelet storage duration and its clinical and transfusion outcomes: a systematic review
por: Aubron, Cécile, et al.
Publicado: (2018) -
A Description of the Type, Frequency and Severity of Infections Among Sixteen Patients Treated for T-Cell Lymphoma
por: Ko, Tina, et al.
Publicado: (2021)